Peter Čamaj

968 total citations
22 papers, 788 citations indexed

About

Peter Čamaj is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Peter Čamaj has authored 22 papers receiving a total of 788 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 13 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Peter Čamaj's work include Cancer Cells and Metastasis (6 papers), interferon and immune responses (4 papers) and Pancreatic and Hepatic Oncology Research (4 papers). Peter Čamaj is often cited by papers focused on Cancer Cells and Metastasis (6 papers), interferon and immune responses (4 papers) and Pancreatic and Hepatic Oncology Research (4 papers). Peter Čamaj collaborates with scholars based in Germany, United States and Slovakia. Peter Čamaj's co-authors include Christiane J. Bruns, Karl‐Walter Jauch, Ivan Ischenko, Enrico N. De Toni, Yue Zhao, Hendrik Seeliger, Peter J. Nelson, Axel Kleespies, Helmut Blum and Qi Bao and has published in prestigious journals such as Cancer Research, Oncogene and Annals of Surgery.

In The Last Decade

Peter Čamaj

22 papers receiving 779 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Čamaj Germany 16 507 355 279 81 78 22 788
Kathy A. Toy United States 17 666 1.3× 358 1.0× 340 1.2× 68 0.8× 85 1.1× 19 999
Alice Agliano Spain 12 431 0.9× 429 1.2× 246 0.9× 100 1.2× 72 0.9× 16 810
Tsutomu Imai Japan 8 595 1.2× 330 0.9× 316 1.1× 75 0.9× 61 0.8× 15 900
Susann Weissmueller United States 5 725 1.4× 414 1.2× 250 0.9× 74 0.9× 119 1.5× 6 992
Е. М. Slonimskaya Russia 15 320 0.6× 307 0.9× 173 0.6× 98 1.2× 94 1.2× 93 617
Elvin Wagenblast United States 9 589 1.2× 434 1.2× 301 1.1× 98 1.2× 97 1.2× 21 923
Alice Faversani Italy 15 644 1.3× 262 0.7× 419 1.5× 61 0.8× 113 1.4× 20 1.0k
Arnaud Guillé France 15 458 0.9× 312 0.9× 353 1.3× 49 0.6× 158 2.0× 42 856
Julia Mitschke Germany 6 545 1.1× 464 1.3× 351 1.3× 102 1.3× 99 1.3× 7 890
Bernard Leroy France 10 453 0.9× 396 1.1× 287 1.0× 34 0.4× 89 1.1× 10 747

Countries citing papers authored by Peter Čamaj

Since Specialization
Citations

This map shows the geographic impact of Peter Čamaj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Čamaj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Čamaj more than expected).

Fields of papers citing papers by Peter Čamaj

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Čamaj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Čamaj. The network helps show where Peter Čamaj may publish in the future.

Co-authorship network of co-authors of Peter Čamaj

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Čamaj. A scholar is included among the top collaborators of Peter Čamaj based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Čamaj. Peter Čamaj is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hering, Nina A., Lisa Hartmann, Peter Čamaj, et al.. (2020). Raloxifene inhibits pancreatic adenocarcinoma growth by interfering with ERβ and IL-6/gp130/STAT3 signaling. Cellular Oncology. 44(1). 167–177. 18 indexed citations
2.
Zhao, Yue, A. Altendorf-Hofmann, Peter Čamaj, et al.. (2017). Elevated interferon-induced protein with tetratricopeptide repeats 3 (IFIT3) is a poor prognostic marker in pancreatic ductal adenocarcinoma. Journal of Cancer Research and Clinical Oncology. 143(6). 1061–1068. 27 indexed citations
3.
Wang, Yan, Yue Zhao, Andreas Herbst, et al.. (2016). miR-221 Mediates Chemoresistance of Esophageal Adenocarcinoma by Direct Targeting of DKK2 Expression. Annals of Surgery. 264(5). 804–814. 68 indexed citations
4.
Zhao, Lu, Yue Zhao, Bettina Schwarz, et al.. (2016). Verapamil inhibits tumor progression of chemotherapy-resistant pancreatic cancer side population cells. International Journal of Oncology. 49(1). 99–110. 50 indexed citations
5.
6.
Čamaj, Peter, Yan Wang, Volker Heinemann, et al.. (2015). KRAS exon 2 mutations influence activity of regorafenib in an SW48-based disease model of colorectal cancer. Future Oncology. 11(13). 1919–1929. 9 indexed citations
7.
Nieß, Hanno, Peter Čamaj, Ivan Ischenko, et al.. (2014). Side population cells of pancreatic cancer show characteristics of cancer stem cells responsible for resistance and metastasis. Targeted Oncology. 10(2). 215–227. 43 indexed citations
8.
Čamaj, Peter, Volker Heinemann, Rüdiger P. Laubender, et al.. (2014). Effect of KRAS exon 2 mutations on antitumor activity of afatinib and gefitinib. Anti-Cancer Drugs. 26(4). 371–378. 8 indexed citations
9.
Čamaj, Peter, Stefan Krebs, Helmut Blum, et al.. (2013). Hypoxia-Independent Gene Expression Mediated by SOX9 Promotes Aggressive Pancreatic Tumor Biology. Molecular Cancer Research. 12(3). 421–432. 22 indexed citations
10.
Zhao, Yue, Qi Bao, Bettina Schwarz, et al.. (2013). Stem Cell-Like Side Populations in Esophageal Cancer: A Source of Chemotherapy Resistance and Metastases. Stem Cells and Development. 23(2). 180–192. 39 indexed citations
11.
Modest, Dominik Paul, Peter Čamaj, Volker Heinemann, et al.. (2013). KRAS allel-specific activity of sunitinib in an isogenic disease model of colorectal cancer. Journal of Cancer Research and Clinical Oncology. 139(6). 953–961. 18 indexed citations
12.
Zhao, Yue, Qi Bao, Peter Čamaj, et al.. (2011). Cancer stem cells and angiogenesis. The International Journal of Developmental Biology. 55(4-5). 477–482. 74 indexed citations
13.
Ischenko, Irene, Hendrik Seeliger, Peter Čamaj, et al.. (2010). Src Tyrosine Kinase Inhibition Suppresses Lymphangiogenesis In Vitro and In Vivo. Current Cancer Drug Targets. 10(5). 546–553. 14 indexed citations
14.
Čamaj, Peter, Hendrik Seeliger, Ivan Ischenko, et al.. (2009). EFEMP1 binds the EGF receptor and activates MAPK and Akt pathways in pancreatic carcinoma cells. Biological Chemistry. 390(12). 1293–1302. 68 indexed citations
15.
Seeliger, Hendrik, Peter Čamaj, Ivan Ischenko, et al.. (2009). EFEMP1 Expression Promotes In vivo Tumor Growth in Human Pancreatic Adenocarcinoma. Molecular Cancer Research. 7(2). 189–198. 75 indexed citations
16.
Ischenko, Ivan, Peter Čamaj, Hendrik Seeliger, et al.. (2008). Inhibition of Src tyrosine kinase reverts chemoresistance toward 5-fluorouracil in human pancreatic carcinoma cells: an involvement of epidermal growth factor receptor signaling. Oncogene. 27(57). 7212–7222. 60 indexed citations
17.
Mucha, Simon, Alexander L. Gerbes, Peter Čamaj, et al.. (2008). JNK inhibition sensitises hepatocellular carcinoma cells but not normal hepatocytes to the TNF-related apoptosis-inducing ligand. Gut. 58(5). 688–698. 52 indexed citations
18.
Toni, Enrico N. De, Christian Kuntzen, Alexander L. Gerbes, et al.. (2006). P60-c-src suppresses apoptosis through inhibition of caspase 8 activation in hepatoma cells, but not in primary hepatocytes. Journal of Hepatology. 46(4). 682–691. 20 indexed citations
19.
Čamaj, Peter, et al.. (2002). Stabilization of threonine production in an Escherichia coli overproducing strain using tightly regulated T7 promoter system. Biotechnology Letters. 24(22). 1893–1897. 1 indexed citations
20.
Čamaj, Peter, Aaron E. Hirsh, Walter Schmidt, Andreas Meinke, & Alexander von Gabain. (2001). Ligand-Mediated Protection against Phage Lysis as a Positive Selection Strategy for the Enrichment of Epitopes Displayed on the Surface of E. coli Cells. Biological Chemistry. 382(12). 1669–77. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kathy A. Toy Breakdown of academic impact, for papers by Alice Agliano Breakdown of academic impact, for papers by Tsutomu Imai Breakdown of academic impact, for papers by Susann Weissmueller Breakdown of academic impact, for papers by Е. М. Slonimskaya Breakdown of academic impact, for papers by Elvin Wagenblast Breakdown of academic impact, for papers by Alice Faversani Breakdown of academic impact, for papers by Arnaud Guillé Breakdown of academic impact, for papers by Julia Mitschke Breakdown of academic impact, for papers by Bernard Leroy
Rankless by CCL
2026